ABT-494 PHARMACOKINETICS FOLLOWING ADMINISTRATION OF THE ONCE-DAILY EXTENDED-RELEASE TABLET FORMULATION BEING UTILIZED IN THE ONGOING RHEUMATOID ARTHRITIS PHASE 3 TRIALS

被引:2
|
作者
Mohamed, M. -E. F. [1 ]
Zeng, J. [1 ]
Song, I. -H. [2 ]
Othman, A. A. [1 ]
机构
[1] AbbVie, Clin Pharmacol & Pharmacometr, N Chicago, IL USA
[2] AbbVie, Immunol Clin Dev, N Chicago, IL USA
关键词
D O I
10.1136/annrheumdis-2017-eular.3224
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
THU0177
引用
收藏
页码:268 / 269
页数:2
相关论文
共 30 条
  • [21] Bioavailability and Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets in Healthy Volunteers: Results from Three Randomized, Crossover, Open-Label, Phase 1 Studies
    Tina deVries
    Angela Dentiste
    Lata Handiwala
    David Jacobs
    Neurology and Therapy, 2019, 8 : 449 - 460
  • [22] Bioavailability and Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets in Healthy Volunteers: Results from Three Randomized, Crossover, Open-Label, Phase 1 Studies
    deVries, Tina
    Dentiste, Angela
    Handiwala, Lata
    Jacobs, David
    NEUROLOGY AND THERAPY, 2019, 8 (02) : 449 - 460
  • [23] LCPT once-daily extended-release tacrolimus tablets versus twice-daily capsules: a pooled analysis of two phase 3 trials in important de novo and stable kidney transplant recipient subgroups
    Bunnapradist, Suphamai
    Rostaing, Lionel
    Alloway, Rita R.
    West-Thielke, Patricia
    Denny, Jason
    Mulgaonkar, Shamkant
    Budde, Klemens
    TRANSPLANT INTERNATIONAL, 2016, 29 (05) : 603 - 611
  • [24] Population Pharmacokinetics of Upadacitinib Using the Immediate-Release and Extended-Release Formulations in Healthy Subjects and Subjects with Rheumatoid Arthritis: Analyses of Phase I–III Clinical Trials
    Ben Klünder
    Rajendar K. Mittapalli
    Mohamed-Eslam F. Mohamed
    Anna Friedel
    Peter Noertersheuser
    Ahmed A. Othman
    Clinical Pharmacokinetics, 2019, 58 : 1045 - 1058
  • [25] Population Pharmacokinetics of Upadacitinib Using the Immediate-Release and Extended-Release Formulations in Healthy Subjects and Subjects with Rheumatoid Arthritis: Analyses of Phase I-III Clinical Trials
    Klunder, Ben
    Mittapalli, Rajendar K.
    Mohamed, Mohamed-Eslam F.
    Friedel, Anna
    Noertersheuser, Peter
    Othman, Ahmed A.
    CLINICAL PHARMACOKINETICS, 2019, 58 (08) : 1045 - 1058
  • [26] Safety and Efficacy of Once-Daily Hydromorphone Extended-Release Versus Twice-Daily Oxycodone Hydrochloride Controlled-Release in Chinese Patients With Cancer Pain: A Phase 3, Randomized, Double-Blind, Multicenter Study
    Yu, Shiying
    Shen, Wei
    Yu, Lu
    Hou, Yanyan
    Han, John
    Richards, Henry M.
    JOURNAL OF PAIN, 2014, 15 (08): : 835 - 844
  • [27] Once-Daily Administration of Trospium Chloride Extended Release Provides 24-hr Coverage of Nocturnal and Diurnal Symptoms of Overactive Bladder: An Integrated Analysis of Two Phase III Trials
    Ginsberg, David A.
    Oefelein, Michael G.
    Ellsworth, Pamela I.
    NEUROUROLOGY AND URODYNAMICS, 2011, 30 (04) : 563 - 567
  • [28] Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial
    Rostaing, Lionel
    Bunnapradist, Suphamai
    Grinyo, Josep M.
    Ciechanowski, Kazimierz
    Denny, Jason E.
    Silva, Helio Tedesco, Jr.
    Budde, Klemens
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2016, 67 (04) : 648 - 659
  • [29] A Randomized Cross-Over Phase 3b Study of the Pharmacokinetics of Once-Daily Extended Release MeltDose® Tacrolimus (Envarsus® XR) Versus Twice-Daily Tacrolimus in African-Americans (ASERTAA)
    Trofe-Clark, J.
    Brennan, D.
    West-Thielke, P.
    Milone, M.
    Lim, M.
    Bloom, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [30] Baricitinib 4mg and 2mg Once-Daily Reduced Pain in Both Patients Who Were Opioid Users and Non-users in Active Rheumatoid Arthritis: A Post-hoc Analysis of Phase 3 Trials
    Pope, Janet
    Lee, Yvonne
    Curtis, Jeffrey
    Mo, Daojun
    Rooney, Terence
    Xie, Li
    Dickson, Christina
    Schlichting, Douglas
    Quebe, Amanda
    Cardoso, Anabela
    Simon, Lee
    Taylor, Peter
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1129 - 1130